Yesterday, the FDA paused use of the Johnson & Johnson COVID-19 due to a rare association with a very uncommon type of blood clot. Detecting one-in-a-million potential adverse events shows that our monitoring is working, but predictably antivaxxers are weaponizing this development to spread fear of COVID vaccines.
